Horm Metab Res 2017; 49(10): 732-738
DOI: 10.1055/s-0043-117892
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Hashimoto’s Thyroiditis is an Important Risk Factor of Papillary Thyroid Microcarcinoma in Younger Adults

Yujuan Liu
1   Department of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, China
2   Department of Nutrition, Qingdao Women and Children’s Hospital, Qingdao, China
,
Chengqian Li
1   Department of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, China
,
Wenjuan Zhao
1   Department of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, China
,
Yangang Wang
1   Department of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, China
› Author Affiliations
Further Information

Publication History

received 24 February 2017

accepted 24 July 2017

Publication Date:
31 August 2017 (online)

Zoom Image

Abstract

The association between autoimmune thyroid disease and thyroid cancer remains unclear. We performed a matched case-control study to assess the association between Hashimoto’s thyroiditis and papillary thyroid microcarcinoma (PTMC). A total of 927 PTMC cases and 927 age- and gender- matched controls selected from the same population were recruited. Odds ratio (OR) with 95% confidence interval (95% CI) was used to assess the strength of the association between Hashimoto’s thyroiditis and PTMC. Conditional logistic regression analysis was carried out, and stratified analyses by age, gender and types of thyroid antibodies were also performed. Hashimoto’s thyroiditis was significantly associated with increased risk of PTMC (OR=1.87, 95% CI 1.49–2.34, p<0.001). Stratified analysis by thyroid antibodies also found obvious associations of PTMC risk with TPOAb positivity (OR=1.58, p=0.001) and TGAb positivity (OR=2.35, p<0.001). Stratified analyses by age showed that the association between Hashimoto’s thyroiditis and PTMC risk was more significant in younger adults aged between 18 and 30 years (OR=11.48, p<0.001). Further stratified analyses by thyroid antibodies also found that the associations of PTMC risk with TPOAb positivity or TGAb positivity were more significant in younger adults aged between 18 and 30, and the ORs were 8.27 (p<0.001) and 12.71 (p<0.001), respectively. This study suggests an obvious relationship between Hashimoto’s thyroiditis and PTMC risk, and Hashimoto’s thyroiditis is an important risk of PTMC in younger adults.